Anaplastic large cell lymphoma

Anaplastic large cell lymphoma
Updated: 08/20/2024
© Jun Wang, MD, PhD

General features
  • Moderately aggressive
  • Likely in young population, men
  • Both nodal and extranodal involvement
  • Most common extranodal sites include skin, bone
  • Morphologically similar to Hodgkin lymphoma
Key pathogenesis
  • Translocation involving ALK (anaplastic lymphoma receptor tyrosine kinase)
  • Abnormal activation of MAPK pathway
Key morphological features
  • Markedly pleomorphic bizarre nuclei:  Horseshoe ("hallmark") cells, wreath-like or multiple nuclei, multiple nucleoli, perinuclear eosinophilic region, occasional nuclear pseudoinclusions ("doughnut" cells)
Markers
  • Positive: CD30, ALK, T-cell markers such as CD5, CD45 (A marker negative in classic type Hodgkin lymphoma)
  • Negative: B cell markers, such as CD20
Genetic abnormalities
  • Translocation involving ALK gene
  • T cell receptor (TCR) gene rearrangement

ALK- anaplastic large cell lymphoma

  • T cell neoplasm with bizarre nuclei but ALK negative
  • More common in 40 - 65 years, slightly more common in male
  • Probably originates from activated T cells
  • Commonly loss of CD3 and other T cell markers
  • Gains of the 1q41-qter and 6p21 common
  • Other molecular abnormalities include: rearrangement involving IRF4 or TP63, and activating mutations of STAT3
  • Morphologically identical with ALK positive ALCL 
  • Positive for CD30, CD45
  • Negative for ALK, EBV
  • Chemotherapy with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or CHOP plus etoposide (CHOEP)




Back to lymphoid neoplasms
Back to contents

Comments

Popular posts from this blog

Contents

Anemia

Female genital tract